Top experts in research and development will present the latest on modern diagnostics, care, biomaterials as well as business development and innovations - even China will be represented
Aachen, 5 February 2010 - When Ernst Schmachtenberg, Rector of RWTH Aachen University opens the fourth BIOMEDICA on March 17, hundreds of life science experts and business development managers will be in Aachen to present on one of the fastest growing fields of the future. The two-day exchange of cutting-edge research by renowned representatives in the life sciences industries around Aachen, Eindhoven, Hasselt, Leuven, Maastricht and Lige has grown to become a prominent conference in Germany, Belgium and the Netherlands. After being hosted in Maastricht and Lige the past two years, BIOMEDICA 2010 returns once again to its origins in Aachen. Also noteworthy is the fact that this is the first time representatives from China will be participating.
The congress and exhibition creates added value from its integrated presentation of formerly individualized topics and by focusing on convergent technologies. "We are meeting for cross-border networking and to provide the most current information first hand," says Fred Bollen, project manager and spokesman for the three-country team managing the organization. The thematic diversity ranges from modern diagnostics, new care models, biomaterials designed for unique requirements, to new business models for patient care and the topic of troubles versus success stories for life science companies. A major exhibition of new products and services also reflects the broad range of current developments.
The first day of the congress offers three parallel sessions on the following topics: "Bringing personalised medicine to the clinic" in the session on disease specific diagnostics; "How to design and maintain multi-party services for extramural care" in the session on integrated care; and "From knowledge valorisation to start-up companies" in the session on business development and product innovation. Renowned speakers such as Dr. Wim Crooijmans from Philips, Dr. Jan Schretlen from PWC and Prof. Michael Goldmann from IMI will give presentations on reliability of services, knowledge valorisation, and the role of Europe's Innovative Medicines Initiative. How fundamental research findings are converted into clinically applicable treatment regimens is answered within the topic of translational medicine, while "Solutions and services for healthcare at home", presented by Dr. Frank van der Scheur of Philips, is the subject of care solutions and services.
Developments in epigenetics, biofunctional materials and business development are the topics for the second conference day. Professor Frans Ramaekers Maastricht University and Professor Martin Mller from the Wool Research Institute at RWTH University in Aachen will present findings from their research. Altogether more than 40 experts from research and industry will give insights into new developments. Keynote speaker, Professor George Guo-Qiang Chen from Tsinghua University in Beijing will present "Medical applications of a new class of biopolymers" as well as research outlooks from China. Prof Randy Jirtle from Duke University in the United States will give a keynote lecture on "Epigenetics: Imprinting and disease susceptibility".
The experience of the last three years has shown that BIOMEDICA presents the highest quality of content together with many opportunities for entering into new networks - particularly across national and disciplinary boundaries. Information and registration can be found at http://www.biomedicasummit.com.
For more information please visit our website at http://www.biomedicasummit.com, or contact us directly:
Maguy de Mercurio
TEMA Technologie Marketing (congress and trade show organization)
Theaterstr. 74
52062 Aachen
Germany
Tel.: +49-241-88970-21
Fax: +49-241-88970-42
Email: mercurio@tema.de
Aachen, 5 February 2010 - When Ernst Schmachtenberg, Rector of RWTH Aachen University opens the fourth BIOMEDICA on March 17, hundreds of life science experts and business development managers will be in Aachen to present on one of the fastest growing fields of the future. The two-day exchange of cutting-edge research by renowned representatives in the life sciences industries around Aachen, Eindhoven, Hasselt, Leuven, Maastricht and Lige has grown to become a prominent conference in Germany, Belgium and the Netherlands. After being hosted in Maastricht and Lige the past two years, BIOMEDICA 2010 returns once again to its origins in Aachen. Also noteworthy is the fact that this is the first time representatives from China will be participating.
The congress and exhibition creates added value from its integrated presentation of formerly individualized topics and by focusing on convergent technologies. "We are meeting for cross-border networking and to provide the most current information first hand," says Fred Bollen, project manager and spokesman for the three-country team managing the organization. The thematic diversity ranges from modern diagnostics, new care models, biomaterials designed for unique requirements, to new business models for patient care and the topic of troubles versus success stories for life science companies. A major exhibition of new products and services also reflects the broad range of current developments.
The first day of the congress offers three parallel sessions on the following topics: "Bringing personalised medicine to the clinic" in the session on disease specific diagnostics; "How to design and maintain multi-party services for extramural care" in the session on integrated care; and "From knowledge valorisation to start-up companies" in the session on business development and product innovation. Renowned speakers such as Dr. Wim Crooijmans from Philips, Dr. Jan Schretlen from PWC and Prof. Michael Goldmann from IMI will give presentations on reliability of services, knowledge valorisation, and the role of Europe's Innovative Medicines Initiative. How fundamental research findings are converted into clinically applicable treatment regimens is answered within the topic of translational medicine, while "Solutions and services for healthcare at home", presented by Dr. Frank van der Scheur of Philips, is the subject of care solutions and services.
Developments in epigenetics, biofunctional materials and business development are the topics for the second conference day. Professor Frans Ramaekers Maastricht University and Professor Martin Mller from the Wool Research Institute at RWTH University in Aachen will present findings from their research. Altogether more than 40 experts from research and industry will give insights into new developments. Keynote speaker, Professor George Guo-Qiang Chen from Tsinghua University in Beijing will present "Medical applications of a new class of biopolymers" as well as research outlooks from China. Prof Randy Jirtle from Duke University in the United States will give a keynote lecture on "Epigenetics: Imprinting and disease susceptibility".
The experience of the last three years has shown that BIOMEDICA presents the highest quality of content together with many opportunities for entering into new networks - particularly across national and disciplinary boundaries. Information and registration can be found at http://www.biomedicasummit.com.
For more information please visit our website at http://www.biomedicasummit.com, or contact us directly:
Maguy de Mercurio
TEMA Technologie Marketing (congress and trade show organization)
Theaterstr. 74
52062 Aachen
Germany
Tel.: +49-241-88970-21
Fax: +49-241-88970-42
Email: mercurio@tema.de